Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)

ISSN
0887-6924
Date Issued
2015
Author(s)
Schuler, E
Giagounidis, A
Platzbecker, U
Nolte, F
Götze, K
Schlenk, R F
Germing, U
DOI
10.1038/leu.2015.340